Financial Is Reata Pharmaceuticals, Inc. (RETA) Going To Reach Wallstreet’s Targets? Reata Pharmaceuticals, Inc. (RETA) has seen some recent movement in the marketplace and its common shares closed trading at $116.71 yesterday. Investors are starting to take notice of RETA as the common shares traded as high as $117.25 and as low as